Intelligent Bio Solutions Inc. (INBS) Liabilities and Shareholders Equity (2020 - 2025)

Intelligent Bio Solutions' Liabilities and Shareholders Equity history runs 6 years deep, the most recent figure standing at $8.2 million for Q2 2025.

• In Q2 2025, Liabilities and Shareholders Equity fell 40.13% year-over-year to $8.2 million; the TTM figure through Jun 2025 stood at $38.2 million (down 20.89% YoY), while the FY2025 annual figure was $8.2 million, down 40.13% from the prior year.
• Liabilities and Shareholders Equity for Q2 2025 stood at $8.2 million, down from $9.6 million in the prior quarter.
• The five-year high for Liabilities and Shareholders Equity was $21.9 million in Q2 2021, with the low at $8.2 million in Q2 2025.
• The 5-year median for Liabilities and Shareholders Equity is $12.0 million (2022), against an average of $13.1 million.
• The sharpest annual moves came in 2021 and 2023: Liabilities and Shareholders Equity surged 782.98% in 2021, then tumbled 51.09% in 2023.
• Intelligent Bio Solutions' Liabilities and Shareholders Equity stood at $15.2 million in 2021, then advanced by 18.46% to $18.0 million in 2022, then sank by 51.09% to $8.8 million in 2023, then fell by 1.62% to $8.7 million in 2024, then dropped by 5.0% to $8.2 million in 2025.
• Business Quant data shows INBS's Liabilities and Shareholders Equity at $8.2 million in Q2 2025, $9.6 million in Q1 2025, and $8.7 million in Q4 2024.